Clinical Trial Update: Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With Clofazimine (C)-TMC207 (J)-PA-824 (Pa)-Pyrazinamide (Z) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating early bactericidal activity of a four-drug regimen (clofazimine, bedaquiline, pretomanid, and pyrazinamide) for pulmonary tuberculosis.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• Bedaquiline (Sirturo) (bedaquiline)
• Clofazimine (Lamprene) (clofazimine)
• Pretomanid (pretomanid)
• Pyrazinamide (pyrazinamide)

Snippet

Sponsor: Global Alliance for TB Drug Development | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2016-12-13